Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 15, 2024 17:00 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024 16:06 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
February 21, 2024 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
February 07, 2024 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
November 15, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx to Participate at Upcoming Investor Conferences
October 31, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx Reports Record Third Quarter 2023 Financial Results
October 30, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023
October 16, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue
October 10, 2023 16:05 ET
|
Pulmonx Corporation
Derrick Sung steps down from his position as Chief Financial Officer to pursue another opportunity; John McKune appointed Interim Chief Financial OfficerPreliminary, unaudited third quarter 2023...
Pulmonx to Participate at Upcoming Investor Conferences
August 30, 2023 16:05 ET
|
Pulmonx Corporation
REDWOOD CITY, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...